Stands on 1 first-party reading of PubMed and ClinicalTrials.gov, not reporting.
Scientist studies effects of Korean red ginseng on uterine leiomyoma growth AI illustrationhow this picture was madeA randomized controlled trial examining effects of Korean red ginseng on uterine leiomyoma is indexed on PubMed and ClinicalTrials.gov as of 2026-11-06 [1].
The trial was double blind and placebo controlled. It was published in the journal Medicine. 69 participants were enrolled. 35 were assigned to Korean red ginseng, 34 to placebo. Follow up ran for 6 months.
61 participants completed the 6 month assessment. All eight participants who did not complete the trial were lost to follow up.
Maximal leiomyoma diameter increased modestly in both groups. No statistically significant between group difference was observed in the change in diameter over the study period. The adjusted mean difference between groups was -0.11 cm, with a 95% confidence interval from -0.33 to 0.12 cm.
The study authors declared no conflicts of interest.
Proof1 source · 1 publisher · signed
What this stands on
"Effects and safety of Korean red ginseng on the clinical course of uterine leiomyoma: A double-blind randomized placebo-controlled trial." published in Medicine as a randomized controlled trial (PubMed 42994854, doi 10.1097/MD.0000000000051173). Sample: 69 as stated in the abstract. Duration: 6 months. Primary outcome: The primary outcome was the between-group difference in the 6-month change in maximal diameter of the index leiomyoma on ultrasonography, analyzed by analysis of covariance adjus · PubMed and ClinicalTrials.gov, read by the New studies instrument · the fact record↗United Statesofficial source
Read directly from PubMed and ClinicalTrials.gov, the public registries of published studies and registered trials, not from anyone's report of it.
